【レポートの概要(一部)】
1. Report Overview
1.1 Global Allergic Rhinitis Drugs: Market Overview
1.2 Global Allergic Rhinitis Drugs Market Segmentation
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Who is This Report For?
1.9 Methodology
1.10 Frequently Asked Questions (FAQ)
1.11 Associated Visiongain Reports
1.12 About Visiongain
2. An Introduction to Allergic Rhinitis Drugs
2.1 The Pharmaceutical Industry: A Brief Introduction
2.1.1 Allergic Rhinitis Treatments – An Industry Overview
2.2 A Brief Overview of Allergy
2.3 Allergic Rhinitis
2.3.1 The Global Prevalence of Allergic Rhinitis
2.3.2 Pathophysiology of Allergic Rhinitis: IgEs and Mast Cells
2.3.3 Symptoms of Allergic Rhinitis
2.3.4 Classification of Allergic Rhinitis
2.3.4.1 Non-Allergic Rhinitis and Mixed Rhinitis
2.3.5 Seasonal Allergic Rhinitis (Hay Fever)
2.3.6 Perennial Allergic Rhinitis
2.3.7 Diagnosis of Allergic Rhinitis
2.4 Treatment of Allergic Rhinitis
2.4.1 Antihistamines
2.4.1.1 First-Generation Antihistamines
2.4.1.2 Second- And Third-Generation Antihistamines
2.4.2 Corticosteroids
2.4.2.1 First-, Second- And Third-Generation Intranasal Corticosteroids
2.4.2.2 Combination Drug Products
2.4.3 Leukotriene Receptor Antagonists
2.4.4 Cromolyn (cromoglicic acid)
2.4.5 Decongestants
2.4.6 Saline Nasal Sprays
2.4.7 Immunotherapy and Vaccines
2.5 Phases of Clinical Trials
2.6 Scope of this Report
3. The Global Allergic Rhinitis Drugs Market, 2016-2026
3.1 The Global Allergic Rhinitis Drugs Market: Market Overview
3.2 Categorisation Of The Global Allergic Rhinitis Drugs Market
3.3 The Global Allergic Rhinitis Drugs Market in 2015
3.4 The Global Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
3.5 Allergic Rhinitis Drugs: Changing Market Shares by Sector 2016-2026
4. Oral Antihistamines Market: Market Analysis And Forecast 2016-2026
4.1 Oral Antihistamines: Market Overview
4.1.1 Leading Products in the Oral Antihistamines Market, 2015
4.2 Oral Antihistamines: Market Trends and Developments, 2016
4.2.1 Patent Expiries and the Threat of Generics
4.2.2 The Increasing Switch from Prescription to Over-The-Counter Sales
4.2.3 The Potential for Combination Therapy with Intranasal Corticosteroids
4.3 Oral Antihistamines: Market Forecast 2016-2026
4.3.1 Oral Antihistamines: Changing Market Shares by Leading Drugs 2016-2026
4.4 Leading Oral Antihistamines for the Treatment of Allergic Rhinitis
4.4.1 Allegra/Allegra-D/Allegra OTC (fexofenadine) – Sanofi
4.4.1.1 Allegra/Allegra OTC: Historical Sales, 1995-2014
4.4.1.2 Allegra/Allegra OTC: Sales Forecast 2015-2026
4.4.2 Claritin/Claritin OTC (loratadine) – Bayer/ Merck & Co
4.4.2.1 Claritin/Claritin OTC: Sales Forecast 2016-2026
4.4.3 Zyrtec/Zyrtec D (cetirizine) – Johnson & Johnson/ UCB/ GSK
4.4.3.1 Zyrtec/Zyrtec D: Sales Forecast 2016-2026
4.4.5 Xyzal (levocetirizine) – Sanofi/ UCB/ GSK
4.4.5.1 Xyzal: Sales Forecast 2016-2026
4.4.6 Clarinex (desloratadine) – Merck & Co.
4.4.6.1 Clarinex: Sales Forecast 2016-2026
4.4.7 Allelock (olopatadine) – Kyowa Hakko Kirin
4.4.7.1 Allelock: Sales Forecast 2016-2026
4.4.8 Ebastel (ebastine) – AstraZeneca/Takeda/Dainippon Sumitomo
4.4.8.1 Ebastel: Sales Forecast 2016-2026
4.4.9 Talion (bepotastine) – Mitsubishi Tanabe
4.4.9.1 Talion: Sales Forecast 2016-2026
4.4.10 Other Oral Antihistamines: Sales Forecast 2016-2026
5. Intranasal Corticosteroids Market: Market Analysis and Forecast 2016-2026
5.1 Leading Products in the Intranasal Corticosteroids Market, 2015
5.2 Intranasal Corticosteroids: Market Forecast 2016-2026
5.2.1 Intranasal Corticosteroids: Changing Market Shares By Leading Drugs 2016-2026
5.3 Leading Intranasal Corticosteroids
5.3.1 Flixonase/Flonase/Flonase-OTC (fluticasone propionate) – GlaxoSmithKline
5.3.1.1 Flixonase/Flonase/Flonase-OTC Forecast, 2016-2026
5.3.2 Nasonex (mometasone) – Merck
5.3.2.1 Nasonex Forecast, 2016-2026
5.3.3 Avamys/Veramyst (fluticasone furoate) – GlaxoSmithKline
5.3.3.1 Avamys/Veramyst Forecast, 2016-2026
5.3.4 Rhinocort (budesonide) – AstraZeneca
5.3.4.1 Rhinocort Forecast, 2016-2026
5.3.5 Nasacort/Nasacort-OTC (triamcinolone) – Sanofi
5.3.5.1 Nasacort/Nasacort-OTC Forecast, 2016-2026
5.3.6 Omnaris (ciclesonide) – Dainippon Sumitomo/Takeda
5.3.6.1 Omnaris: Sales Forecast, 2016-2026
5.3.7 Beconase/Beconase AQ (beclometasone) – GlaxoSmithKline/Omega Pharma
5.3.7.1 Beconase/Beconase AQ Forecast, 2016-2026
5.3.8 Qnasl (beclometasone) – Teva
5.3.8.1 Qnas Forecast, 2016-2026
5.3.9 Zetonna (ciclesonide) – Dainippon Sumitomo
5.3.9.1 Zetonna Forecast, 2016-2026
6. Immunotherapy and Vaccines: Market Analysis and Forecast 2016-2026
6.1 Immunotherapy and Vaccines: Market Overview
6.1.1 Immunotherapy: Primed for Rapid Expansion
6.2 Leading Immunotherapy Products in the Allergic Rhinitis Market, 2015
6.3 Allergic Rhinitis Immunotherapy: Market Trends and Developments, 2016
6.3.1 Subcutaneous and Sublingual Immunotherapy
6.3.2 Expansion into the US Market
6.3.3 Standardisation of Immunotherapy Products
6.3.4 Immunotherapy as a Preventative Treatment
6.4 Allergic Rhinitis Immunotherapy: Market Forecast 2016-2026
6.4.1 Allergic Rhinitis Immunotherapy: Changing Market Shares by Leading Products 2016-2026
6.5 Immunotherapy Type – By Route of Administration, 2015
6.6 Leading Immunotherapy Products for Allergic Rhinitis
6.6.1 Staloral (Grass pollen allergen extract) – Stallergenes
6.6.1.1 Staloral: Sales Forecast 2016-2026
6.6.2 Alutard SQ (Grass pollen allergen extract) – ALK-Abelló
6.6.2.1 Alutard SQ: Sales Forecast 2016-2026
6.6.3 Grazax/Grastek (Timothy grass pollen allergen extract) – ALK-Abelló/Merck
6.6.3.1 Grazax/Grastek: Sales Forecast 2016-2026
6.6.4 Oralair (Grass pollen allergen extract) – Stallergenes/Greer
6.6.4.1 Oralair: Sales Forecast 2016-2026
6.6.5 Ragwitek (Short ragweed pollen allergen extract) – Merck
6.6.5.1 Ragwitek: Sales Forecast 2016-2026
6.6.6 Other Allergic Rhinitis Immunotherapy Products: Sales Forecast 2016-2026
7. The Intranasal Antihistamines Market: Market Analysis and Forecast 2016-2026
7.1 Leading Products in the Intranasal Antihistamines Market, 2015
7.2 Intranasal Antihistamines: Market Trends and Developments, 2016
7.3 Intranasal Antihistamines: Market Forecast 2016-2026
7.4 Leading Intranasal Antihistamines
7.4.1 Dymista (azelastine/fluticasone) – Meda Pharmaceuticals
7.4.1.1 Mylan Acquires Meda Pharmaceuticals
7.4.1.2 Dymista: Sales Forecast 2016-2026
7.4.2 Generic Intranasal Azelastine
7.4.2.1 Generic Intranasal Azelastine: Sales Forecast, 2016-2026
7.4.3 Astepro (azelastine) – Meda Pharmaceuticals
7.4.3.1 Astepro: Sales Forecast 2016-2026
7.4.4 Patanase (olopatadine) – Novartis
7.4.4.1 Patanase: Sales Forecast 2016-2026
7.4.5 Astelin (azelastine) – Meda Pharmaceuticals
7.4.5.1 Astelin: Sales Forecast 2016-2026
8. Leading National Markets for Allergic Rhinitis Drugs, 2016-2026
8.1 The Allergic Rhinitis Drugs Market by Region
8.1.1 The Global Distribution of Allergic Rhinitis Drugs in 2015
8.2 Leading National Markets: Forecast 2016-2026
8.2.1 Changing Market Shares by Region, 2016-2026
8.3 Regional Allergic Rhinitis Drugs Markets: Analysis and Forecasts, 2016-2026
8.3.1 United States: The Largest Allergic Rhinitis Drugs Market
8.3.1.1 US Allergic Rhinitis Drugs Market: Trends and Developments
8.3.1.1.1 The Trend of Rx-to-OTC Switching
8.3.1.2 US Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2 EU5
8.3.2.1 EU5 Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.2 EU5 Markets: Changing Market Shares by Country, 2016-2026
8.3.2.3 Germany
8.3.2.3.1 Germany: Reform of AMNOG Pharmaceutical Rebate Law
8.3.2.3.2 German Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.4 UK
8.3.2.4.1 UK: Increasing Burden of Allergy
8.3.2.4.2 UK Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.5 France
8.3.2.5.1 France: Social Security Finance Act 2015
8.3.2.5.2 French Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.6 Italy
8.3.2.6.1 Italy: Government Cost Cutting Measures Impacting Market Growth
8.3.2.6.2 Italian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.3.2.7 Spain
8.3.2.7.1 Spanish Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.6 China
8.6.1 Air Pollution Associated With Increasing Prevalence
8.6.2 Expansion of Healthcare Coverage and Reimbursement in China
8.6.3 Chinese Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.7 Japan
8.7.1 Cedar Reforestation and the Hay Fever Epidemic
8.7.2 Genetically Modified Rice as Immunotherapy
8.7.3 Effects of the Rising Levels of Generic Drug Penetration
8.7.4 Japanese Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.8 Russia
8.8.1 How Will Russia’s Economic Status Affect Its Pharma Industry?
8.8.2 Russian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.9 India
8.9.1 The Impact of the Drug Prices Control Order on Indian Pharma
8.9.2 India’s Expansion of Healthcare Provision
8.9.3 Indian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.10 Brazil
8.10.1 How Will Brazil’s Growing Healthcare Influence Allergic Rhinitis Drugs
8.10.2 Brazilian Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
8.12 Rest of the World
8.12.1 Rest of the World Allergic Rhinitis Drugs Market: Market Forecast 2016-2026
9. Leading Companies in the Allergic Rhinitis Drugs Market, 2016-2026
9.1 Allergic Rhinitis Drugs – An Evolving Market Space
9.1.1 Leading Companies in the Allergic Rhinitis Drugs Market, 2016
9.2 ALK-Abelló
9.2.1 ALK-Abelló: Allergic Rhinitis Drugs Portfolio, 2016
9.2.2 ALK-Abelló: Recent Developments
9.2.2.1 Acarizax Launched in Europe progressing to International Roll-Out
9.2.2.2 ALK Collaborates With EddingPharm to Boost China Sales
9.2.2.3 ALK-Abelló: Sales Forecast 2016-2026
9.2.2.4 ALK-Abelló: Allergic Rhinitis Drug Development Pipeline, 2016
9.3 GlaxoSmithKline (GSK)
9.3.1 GlaxoSmithKline: Allergic Rhinitis Drugs Portfolio, 2016
9.3.2 GlaxoSmithKline: Sales Forecast 2016-2026
9.4 Johnson & Johnson
9.4.1 Johnson & Johnson: Allergic Rhinitis Drugs Portfolio, 2016
9.4.2 Johnson & Johnson: Recent Developments
9.4.2.1 Manufacturing Recalls At McNeil Consumer Healthcare
9.4.2.2 Johnson & Johnson: Sales Forecast 2016-2026
9.5 Kyowa Hakko Kirin
9.5.1 Kyowa Hakko Kirin: Allergic Rhinitis Drugs Portfolio, 2015
9.5.2 Kyowa Hakko Kirin: Sales Forecast 2016-2026
9.6 Merck & Co.
9.6.1 Merck: Allergic Rhinitis Drugs Portfolio, 2016
9.6.2 Merck: Recent Developments
9.6.2.1 Bayer Acquires Merck’s Consumer Health Business
9.6.2.2 FDA Rejects Singulair OTC Switch
9.2.6.3 Merck: Sales Forecast 2016-2026
9.2.6.4 Merck: Allergic Rhinitis Drug Development Pipeline, 2016
9.7 Sanofi
9.7.1 Sanofi: Allergic Rhinitis Drugs Portfolio, 2016
9.7.2 Sanofi: Sales Forecast 2016-2026
9.8 Stallergenes Greer
9.8.1 Stallergenes: Allergic Rhinitis Drugs portfolio, 2015
9.8.2 Stallergenes Greer: Sales Forecast 2016-2026
9.8.3 Stallergenes Greer: Allergic Rhinitis Drug Development Pipeline, 2015
9.9 UCB
9.9.1 UCB: Allergic Rhinitis Drugs Portfolio, 2015
9.9.2 UCB: Sales Forecast 2016-2026
9.10 Other Leading Companies within the Allergic Rhinitis Drugs Market
10. Allergic Rhinitis Drugs: Research and Development Pipeline, 2016-2026
10.1 Trends and Developments in the Allergic Rhinitis Pipeline
10.2 The R&D Pipeline for Oral Antihistamines, 2016
10.2.1 Talion (bepotastine) – Mitsubishi Tanabe
10.2.2 ZPL-3893787 (histamine H4R antagonist) – Ziarco Pharma
10.3 The R&D Pipeline for Intranasal Corticosteroids, 2016
10.3.1 APC-3000 (HFA inhaled corticosteroid) – Adamis Pharmaceuticals
10.3.2 TBS-6 – Trimel Pharmaceuticals
10.4 The R&D Pipeline for Immunotherapy in Allergic Rhinitis, 2016
10.4.1 Actair (house dust mite SLIT; STG320) – Stallergenes/Shionogi & Co
10.4.2 AllerT (subcutaneous birch pollen immunotherapy) – Anergis
10.4.3 Depigoid Birch 5000 (birch pollen allergen extract, Leti Pharma
10.4.4 House Dust Mite SLIT-Tablet (MK-8237) – ALK-Abelló/Merck/Torii
10.4.5 Pollinex Quattro (subcutaneous immunotherapies) – Allergy Therapeutics
10.4.6 gp-ASIT+ (grass pollen allergen fragments) – Biotech Tools
10.4.7 Betula verrucosa (Bet v) 1 allergen – Stallergenes Greer
10.5 The R&D Pipeline for Other Allergic Rhinitis Drugs
10.5.1 S-555739 (prostaglandin D2 receptor antagonist) – Shionogi
10.5.2 DSP-3025/AZD-8848 (toll-like receptor 7 agonist) – Dainippon Sumitomo/ AstraZeneca
10.5.3 GSK2245035 (toll-like receptor 7 agonist) – GSK
10.5.4 HP-3060 (transdermal long-acting tape) – Hisamitsu
10.5.5 MRX-4 (anti-inflammatory agent) – Celsus Therapeutics
11. Qualitative Analysis of the Allergic Rhinitis Drugs Market, 2016-2026
11.1 Market Factors Influencing Allergic Rhinitis Drugs
11.2 SWOT Analysis Of The Global Allergic Rhinitis Drugs Market, 2016-2026
11.2.1 Strengths
11.2.1.1 OTC-Switch Facilitating Ease Of Consumer Access
11.2.1.2 The Established Role Of Allergic Rhinitis Drugs In Treatment
11.2.1.3 Allergic Rhinitis And The Rising Unmet Clinical Need
11.2.1.4 Rising Profile of Allergic Rhinitis In Various Regions Driving Healthcare Provision
11.2.2 Weaknesses
11.2.2.1 Intranasal Corticosteroids And Patients’ Satisfaction Rates
11.2.2.2 Increasing Penetration Of Generic Drug Products
11.2.2.3 The Challenge Raised By The Low Volume Of Pipeline Developments
11.2.3 Opportunities
11.2.3.1 Growth In Emerging Markets Outstripping Established Markets
11.2.3.2 Rx-to-OTC Switching And The Effects On Revenue Potential
11.2.3.3 Combination Drug Products Providing Rising Efficacy Profiles
11.2.3.4 The Emergence Of Immunotherapy In Allergic Rhinitis
11.2.4 Threats
11.2.4.1 Cost-Containment As A Growth Restraint
11.2.4.2 Rising Cost Of APIs And Manufacturing
11.2.4.3 Patent Expiries And The Resultant Loss Of Revenue
11.3 Porter’s Five Force Analysis of the Global Allergic Rhinitis Drugs Market, 2016-2026
11.3.1 Power of Buyers
11.3.2 Power Of Suppliers
11.3.3 Threat of Substitutes
11.3.4 Threat Of New Entrants
11.3.5 Rivalry Among Competitors
12. Conclusions
12.1 Overview of Current Market Conditions and Market Forecast, 2015-2026
12.2 Leading Sectors in the Allergic Rhinitis Drugs Market in 2015
12.3 Leading Regions in the Allergic Rhinitis Drugs Market in 2015
12.4 Leading Companies in the Allergic Rhinitis Drugs Market, 2015
12.5 What Does The Future Hold For Allergic Rhinitis Drugs?
【レポート販売概要】
■ タイトル:アレルギー性鼻炎治療薬の世界市場予測2016-2026■ 英文:Allergic Rhinitis Drugs Market Forecast 2016-2026
■ 発行日:2016年9月
■ 調査会社:visiongain
■ 商品コード:VGAIN61118
■ 調査対象地域:グローバル
- 癒着防止剤の世界市場:ヒアルロン酸、フィブリン、再生セルロース、コラーゲン、タンパク質The global adhesion barrier market is expected to reach USD 1,216.8 Million by 2021 from USD 812.5 Million in 2016, at a CAGR of 8.4% during the forecast period of 2016 to 2021. Rising geriatric population, increasing number of surgeries, and growth in the number of sports-related and hand and wrist injuries are the major factors driving the adhesion barrier market. However, limited technological …
- 感圧接着剤の世界市場:水性感圧接着剤、溶剤型感圧接着剤、ホットメルト感圧接着剤、放射線感圧接着剤Pressure sensitive adhesives (PSA) are non-metallic materials used to bond different materials, mainly on their surface, through adhesion and cohesion. Water, or heat is not required to apply the adhesive. The adhesives occupy the largest market share in the adhesives business. They are either permanent or removable and can match with a variety of substrates. The major materials used in formulatin …
- フェノール樹脂の世界市場分析:製品別(ノボラック、レゾルツ)、用途別(木材接着剤、成形材料、断熱材、ラミネート、紙含浸・コーティング)、競争戦略、セグメント予測、2014-2025The global phenolic resins market is projected to reach USD 16.0 billion by 2025, according to a new report by Grand View Research, Inc. Technological advancements have fostered the development of unique heat shields with ablative phenolics for aerospace applications, leading to greater market share in recent years. Development of lignin and corn-based renewable feedstock have also presented new g …
- 定量濾紙・定性濾紙の世界市場2016-2020About the Qualitative and Quantitative Filter Market Filter papers are semi-permeable paper barriers used to filter fine particles in liquids. The filter paper is placed perpendicular to the direction of the flowing liquid and the retains undissolved substances in the liquid. Two types of filter papers, quantitative and qualitative filters, are commonly employed for laboratory applications. Quanti …
- 集光型太陽光発電の世界市場(~2019)This report estimates the concentrated photovoltaic market in terms of value. The global concentrated photovoltaic market is segmented based on their concentration levels, which include high, medium, and low. The market is further segmented on the basis of regions such as Asia-Pacific, Europe, the Middle East & Africa, and Americas as well as on the basis of technologies such as refractors and ref …
- 電子製品用グラフェン素材 の世界市場:グラフェン材料、グラフェンデバイス、グラフェン製品Graphene is a wonder material which is useful for all major industry segments present in the market such as energy, aerospace, automotive, biomedical & life science, coating, composites, sensors and, electronics among others. Graphene electronics means the use of Graphene in the electronic application such as computing application sector, data storage application sector, consumer application secto …
- 世界のスーパージャンクションMOSFET(SJ-MOSFET)市場動向(2012-2016)TechNavio's analysts forecast the Global Super Junction Metal-Oxide-Semiconductor Field-Effect Transistor (MOSFET) market to grow at a CAGR of 13.9 percent over the period 2012-2016. The deployment of super junction MOSFETs into power supplies reduces the power supplies’ size and this is one of the key factors contributing to the market growth. The Global Super Junction MOSFET market has also been …
- 人工知能(AI)の世界市場:機械学習、自然言語処理、画像処理、音声認識MarketsandMarkets forecasts the artificial intelligence market to grow from USD 419.7 Million in 2014 to USD 5.05 Billion by 2020, at a CAGR of 53.65% from 2015 to 2020. The major factors driving the growth of this market include diversified application areas of AI, improved productivity, and increased level of customer satisfaction. In addition, the rising demand for intelligent systems is expect …
- 自動車用パワートレイン試験サービスの世界市場2019-2023About this market In developing countries, the local implementations of emissions standards are derived from the three major legislative standards of EPA, EURO and Japanese standards. These emission control regulations force automotive manufacturers to improve the efficiency of the engine using different methods. Stringent emission control norms will be the major drivers for the market. European O …
- ソフトウェア定義(SDx)の世界市場予測(~2024年)Increasing big data generation by enterprises and their increasing demand for virtualization and cloud in data centers to drive the market growth of SDx solutionsThe global Software-Defined Anything (SDx) market size is expected to grow from 51.7 billion in 2019 to USD 160.8 by 2024, at a Compound Annual Growth Rate (CAGR) of 25.5% during the forecast period. Organizations worldwide are increasing …
- 天然ガス自動車(NGV)の世界市場:燃料(CNG車、LNG車)、商用車(バス、トラック)、燃料補給インフラ(天然ガススタンド)、地域別分析Due to stringent emissions regulations rolled out by governments in an effort to improve air quality, public as well as transit and logistic agencies have turned to alternative fuels. In addition to the obvious environmental benefits, reduced operating costs and government incentives have spurred the increased use of alternative fuels in the transit industry. CNG and LNG are amongst the most popul …
- サウジアラビアの小売市場2016-2020About the Retail Market in Saudi Arabia The increase in oil prices between 2003 and 2013 brought prosperity in Saudi Arabia and it became the world's 90-largest economy. The hike in oil prices brought growth across sectors, and the GDP; household income; employment levels; and government investments in health, infrastructure, and education increased. However, the government cannot rely solely on r …
- 電気自動車用リチウムイオンバッテリーの世界市場About Li-ion Battery for AEVs Li-ion batteries are extensively used as a power source in AEVs. They are used as an alternative source of power in HEVs, and as a primary source of power in BEVs and PHEVs. BEVs and PHEVs use electric motors, powered by Li-ion batteries, for propulsion. The application base of Li-ion batteries is higher in BEVs and PHEVs because of their high energy density and long …
- シングルユース・バイオプロセシングの世界市場予測(~2021年):シングルユース・メディアバック/容器、シングルユース・バイオリアクター、濾過アセンブリThe global single-use bioprocessing market is poised to reach USD 5.44 Billion by 2021 from USD 2.47 Billion in 2016, at a CAGR of 17.8% from 2016 to 2021. In this report, the global market is broadly segmented by product, application, end user, and region. Major factors fueling market growth are the increasing demand for biopharmaceuticals, high energy efficiency, low water usage, less floor spac …
- 足・足首装具の世界市場About Foot and Ankle DevicesFoot and ankle devices are used for the correction and recuperation of the foot and ankle damaged by injuries or musculoskeletal disorders. The devices can also be used for orthopedic disorders such as osteoarthritis, osteoporosis, bunions, and hammertoes, as well as any congenital or neuropathic condition such as a diabetic foot that requires surgical/non-surgical corr …